Global Womens Health Market 2016-2020

女性医療の世界市場:閉経後骨粗鬆症、避妊、不妊、閉経、子宮内膜症、多嚢胞性卵巣症候群

◆タイトル:Global Womens Health Market 2016-2020
◆商品コード:IRTNTR9224
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2016年4月12日
◆ページ数:65
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥336,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、女性医療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、女性医療の世界市場規模及び予測、用途別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Women’s Health Market
Women’s health refers to the overall well-being experienced by women — this includes physical, mental, and social well-being. It deals with the diagnosis and treatment of various diseases and conditions that affect women such as HIV/AIDS, endometriosis, infertility, polycystic ovary syndrome, postmenopausal osteoporosis, and cancer (primarily ovarian and breast cancer). It also includes issues other than the biological conditions, like gender inequality (women are sometimes not able to afford medical treatments) or other socioeconomic issues.

Technavio’s analysts forecast the global women’s health market to grow at a CAGR of 3.84% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global women’s health market for 2016-2020. To calculate the market size, the report considers the revenue generated by the sales of drugs and devices for women’s health issues.

The market is divided into the following segments based on geography:
• Americas
• APAC
• Europe
• MEA

Technavio’s report, Global Women’s Health Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Allergan
• Bayer HealthCare
• Merck
• Pfizer
• Teva Pharmaceuticals

[Other prominent vendors]
• Agile Therapeutics
• Amgen
• Apothecus Pharmaceutical
• AstraZeneca
• Blairex Laboratories
• Bristol-Myers Squibb
• EffRx
• Ferring International Center
• GlaxoSmithKline
• HLL Lifecare
• Janssen Pharmaceutical
• Lipocine
• Ligand Pharmaceuticals
• Lupin Pharmaceuticals
• Mayer Laboratories
• Medicines 360
• Neurocrine Biosciences
• Novartis
• Novo Nordisk
• Pantarhei Bioscience
• Sanofi

[Market driver]
• Rise in number of older women worldwide
• For a full, detailed list, view our report

[Market challenge]
• High cost and inaccessibility of health services
• For a full, detailed list, view our report

[Market trend]
• Rise in STIs
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by application
• Market overview
• Global postmenopausal osteoporosis market
• Global contraceptives market
• Global infertility market
• Global menopause market
• Global endometriosis market
• Global polycystic ovary syndrome market

PART 07: Geographical segmentation
• Market overview
• Women’s health market in Americas
• Women’s health market in Europe
• Women’s health market in APAC
• Women’s health market in MEA

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• Allergan
• Bayer HealthCare
• Merck
• Pfizer
• Teva Pharmaceuticals
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

PART 16: Explore Technavio

[List of Exhibits]

Exhibit 01: Global women’s health market segmentation
Exhibit 02: Product offerings
Exhibit 03: Global women’s health market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global women’s health market segmentation by application 2015
Exhibit 06: Global women’s health market segmentation by application 2020
Exhibit 07: Global women’s health market by application 2015-2020 ($ billions)
Exhibit 08: Global women’s health market by application 2015-2020 (% share)
Exhibit 09: Global postmenopausal osteoporosis market 2015-2020 ($ billions)
Exhibit 10: Global contraceptives market 2015-2020 ($ billions)
Exhibit 11: Global infertility market 2015-2020 ($ billions)
Exhibit 12: Global menopause market 2015-2020 ($ billions)
Exhibit 13: Global endometriosis market 2015-2020 ($ billions)
Exhibit 14: Global polycystic ovary syndrome market 2015-2020 ($ millions)
Exhibit 15: Global women’s health market geographical segmentation 2015
Exhibit 16: Global women’s health market geographical segmentation 2015-2020 ($ billions)
Exhibit 17: Women’s health market in Americas 2015-2020 ($ billions)
Exhibit 18: Women’s health market in Europe 2015-2020 ($ billions)
Exhibit 19: Women’s health market in APAC 2015-2020 ($ billions)
Exhibit 20: Women’s health market in MEA 2015-2020 ($ billions)
Exhibit 21: Average annual per capita growth in health spending and share of GDP in emerging countries and OECD for 2013-2014
Exhibit 22: Impact of drivers
Exhibit 23: Impact of drivers and challenges
Exhibit 24: Companies focusing on women’s health
Exhibit 25: Allergan: Key takeaways
Exhibit 26: Bayer HealthCare: Key takeaways
Exhibit 27: Merck: Key takeaways
Exhibit 28: Pfizer: Key takeaways
Exhibit 29: Teva Pharmaceuticals: Key takeaways



【掲載企業】

Allergan, Bayer HealthCare, Merck, Pfizer, Teva Pharmaceuticals, Agile Therapeutics, Amgen, Apothecus Pharmaceutical, AstraZeneca, Blairex Laboratories, Bristol-Myers Squibb, EffRx, Ferring International Center, GlaxoSmithKline, HLL Lifecare, Janssen Pharmaceutical, Lipocine, Ligand Pharmaceuticals, Lupin Pharmaceuticals, Mayer Laboratories, Medicines 360, Neurocrine Biosciences, Novartis, Novo Nordisk, Pantarhei Bioscience, Sanofi.

【資料のキーワード】

女性医療、閉経後骨粗鬆症、避妊、不妊、閉経、子宮内膜症、多嚢胞性卵巣症候群

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[女性医療の世界市場:閉経後骨粗鬆症、避妊、不妊、閉経、子宮内膜症、多嚢胞性卵巣症候群] (Global Womens Health Market 2016-2020 / IRTNTR9224)販売に関する免責事項
[女性医療の世界市場:閉経後骨粗鬆症、避妊、不妊、閉経、子宮内膜症、多嚢胞性卵巣症候群] (Global Womens Health Market 2016-2020 / IRTNTR9224)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆